To identify the potential mechanism mediating the tumor-inhibitory effects of LINC01852, we performed RNA pull-down assays to isolate LINC01852-associated proteins from CRC cells (Fig. 4A). This evidence concerns the gene LINC01852 and colorectal carcinoma.